Cell-free DNA in the Circulation as a Potential Cancer Biomarker

In the course of the search for new biomarkers, circulating cell-free DNA (ccf-DNA) has become a popular target of interest. An elevated level of ccf-DNA has been detected in the circulation of cancer patients in comparison with healthy controls. Since ccf-DNA in cancer patients often bears similar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anticancer research 2011-08, Vol.31 (8), p.2623-2628
Hauptverfasser: KOHLER, Corina, BAREKATI, Zeinab, RADPOUR, Ramin, YAN ZHONG, Xiao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2628
container_issue 8
container_start_page 2623
container_title Anticancer research
container_volume 31
creator KOHLER, Corina
BAREKATI, Zeinab
RADPOUR, Ramin
YAN ZHONG, Xiao
description In the course of the search for new biomarkers, circulating cell-free DNA (ccf-DNA) has become a popular target of interest. An elevated level of ccf-DNA has been detected in the circulation of cancer patients in comparison with healthy controls. Since ccf-DNA in cancer patients often bears similar genetic and epigenetic features to the related tumor DNA, there is evidence that some of the ccf-DNA originates from tumoral tissue. This, and the fact that ccf-DNA can easily be isolated from the circulation and other body fluids of patients, makes it a promising candidate as a non-invasive biomarker of cancer. Yet ccf-DNA-based cancer tests have not come to fruitful clinical applications. This review evaluates the potential of ccf-DNA alterations as a biomarker for cancer management by addressing the question of how large the gap between ccf-DNA and the ideal cancer biomarker is.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_907178867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>907178867</sourcerecordid><originalsourceid>FETCH-LOGICAL-p272t-4156f83bcfc006288c56892777031e807a899e9e583687c9d7de9ca0acca7abd3</originalsourceid><addsrcrecordid>eNqF0DtPwzAUBWALgWgp_AXkBTFF8iPxtTdKKA-pAgaYo1vnRhjSpNjJwL8nEkWMTHf5dHTOPWBzCU5mUGhxyOZCFSIDIYoZO0npXQhjnNXHbKYkgNUyn7Orkto2ayIRv3lc8tDx4Y14GaIfWxxC33FMHPlzP1A3BGx5iZ2nyK9Dv8X4QfGUHTXYJjrb3wV7vV29lPfZ-unuoVyus50CNWS5LExj9cY3fqqhrPWFsU4BgNCSrAC0zpGjwmpjwbsaanIeBXqPgJtaL9jlT-4u9p8jpaHahuSn8thRP6bKCZBgrYF_pZ2YUuDUJM_3ctxsqa52MUyjvqrf90zgYg8weWybOI0P6c_luTHS5vobUM9sgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>878822792</pqid></control><display><type>article</type><title>Cell-free DNA in the Circulation as a Potential Cancer Biomarker</title><source>Elektronische Zeitschriftenbibliothek (Open access)</source><source>MEDLINE</source><creator>KOHLER, Corina ; BAREKATI, Zeinab ; RADPOUR, Ramin ; YAN ZHONG, Xiao</creator><creatorcontrib>KOHLER, Corina ; BAREKATI, Zeinab ; RADPOUR, Ramin ; YAN ZHONG, Xiao</creatorcontrib><description>In the course of the search for new biomarkers, circulating cell-free DNA (ccf-DNA) has become a popular target of interest. An elevated level of ccf-DNA has been detected in the circulation of cancer patients in comparison with healthy controls. Since ccf-DNA in cancer patients often bears similar genetic and epigenetic features to the related tumor DNA, there is evidence that some of the ccf-DNA originates from tumoral tissue. This, and the fact that ccf-DNA can easily be isolated from the circulation and other body fluids of patients, makes it a promising candidate as a non-invasive biomarker of cancer. Yet ccf-DNA-based cancer tests have not come to fruitful clinical applications. This review evaluates the potential of ccf-DNA alterations as a biomarker for cancer management by addressing the question of how large the gap between ccf-DNA and the ideal cancer biomarker is.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>PMID: 21778314</identifier><language>eng</language><publisher>Attiki: International Institute of Anticancer Research</publisher><subject>Biological and medical sciences ; Biomarkers, Tumor - blood ; Biomarkers, Tumor - genetics ; DNA - blood ; DNA - genetics ; Epigenesis, Genetic ; Humans ; Medical sciences ; Microsatellite Repeats - genetics ; Tumors</subject><ispartof>Anticancer research, 2011-08, Vol.31 (8), p.2623-2628</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>310,311,315,781,785,790,791,23934,23935,25144</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24466184$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21778314$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KOHLER, Corina</creatorcontrib><creatorcontrib>BAREKATI, Zeinab</creatorcontrib><creatorcontrib>RADPOUR, Ramin</creatorcontrib><creatorcontrib>YAN ZHONG, Xiao</creatorcontrib><title>Cell-free DNA in the Circulation as a Potential Cancer Biomarker</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>In the course of the search for new biomarkers, circulating cell-free DNA (ccf-DNA) has become a popular target of interest. An elevated level of ccf-DNA has been detected in the circulation of cancer patients in comparison with healthy controls. Since ccf-DNA in cancer patients often bears similar genetic and epigenetic features to the related tumor DNA, there is evidence that some of the ccf-DNA originates from tumoral tissue. This, and the fact that ccf-DNA can easily be isolated from the circulation and other body fluids of patients, makes it a promising candidate as a non-invasive biomarker of cancer. Yet ccf-DNA-based cancer tests have not come to fruitful clinical applications. This review evaluates the potential of ccf-DNA alterations as a biomarker for cancer management by addressing the question of how large the gap between ccf-DNA and the ideal cancer biomarker is.</description><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - blood</subject><subject>Biomarkers, Tumor - genetics</subject><subject>DNA - blood</subject><subject>DNA - genetics</subject><subject>Epigenesis, Genetic</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Microsatellite Repeats - genetics</subject><subject>Tumors</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0DtPwzAUBWALgWgp_AXkBTFF8iPxtTdKKA-pAgaYo1vnRhjSpNjJwL8nEkWMTHf5dHTOPWBzCU5mUGhxyOZCFSIDIYoZO0npXQhjnNXHbKYkgNUyn7Orkto2ayIRv3lc8tDx4Y14GaIfWxxC33FMHPlzP1A3BGx5iZ2nyK9Dv8X4QfGUHTXYJjrb3wV7vV29lPfZ-unuoVyus50CNWS5LExj9cY3fqqhrPWFsU4BgNCSrAC0zpGjwmpjwbsaanIeBXqPgJtaL9jlT-4u9p8jpaHahuSn8thRP6bKCZBgrYF_pZ2YUuDUJM_3ctxsqa52MUyjvqrf90zgYg8weWybOI0P6c_luTHS5vobUM9sgA</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>KOHLER, Corina</creator><creator>BAREKATI, Zeinab</creator><creator>RADPOUR, Ramin</creator><creator>YAN ZHONG, Xiao</creator><general>International Institute of Anticancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>7TM</scope></search><sort><creationdate>20110801</creationdate><title>Cell-free DNA in the Circulation as a Potential Cancer Biomarker</title><author>KOHLER, Corina ; BAREKATI, Zeinab ; RADPOUR, Ramin ; YAN ZHONG, Xiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p272t-4156f83bcfc006288c56892777031e807a899e9e583687c9d7de9ca0acca7abd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - blood</topic><topic>Biomarkers, Tumor - genetics</topic><topic>DNA - blood</topic><topic>DNA - genetics</topic><topic>Epigenesis, Genetic</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Microsatellite Repeats - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KOHLER, Corina</creatorcontrib><creatorcontrib>BAREKATI, Zeinab</creatorcontrib><creatorcontrib>RADPOUR, Ramin</creatorcontrib><creatorcontrib>YAN ZHONG, Xiao</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Nucleic Acids Abstracts</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KOHLER, Corina</au><au>BAREKATI, Zeinab</au><au>RADPOUR, Ramin</au><au>YAN ZHONG, Xiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cell-free DNA in the Circulation as a Potential Cancer Biomarker</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>31</volume><issue>8</issue><spage>2623</spage><epage>2628</epage><pages>2623-2628</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>In the course of the search for new biomarkers, circulating cell-free DNA (ccf-DNA) has become a popular target of interest. An elevated level of ccf-DNA has been detected in the circulation of cancer patients in comparison with healthy controls. Since ccf-DNA in cancer patients often bears similar genetic and epigenetic features to the related tumor DNA, there is evidence that some of the ccf-DNA originates from tumoral tissue. This, and the fact that ccf-DNA can easily be isolated from the circulation and other body fluids of patients, makes it a promising candidate as a non-invasive biomarker of cancer. Yet ccf-DNA-based cancer tests have not come to fruitful clinical applications. This review evaluates the potential of ccf-DNA alterations as a biomarker for cancer management by addressing the question of how large the gap between ccf-DNA and the ideal cancer biomarker is.</abstract><cop>Attiki</cop><pub>International Institute of Anticancer Research</pub><pmid>21778314</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0250-7005
ispartof Anticancer research, 2011-08, Vol.31 (8), p.2623-2628
issn 0250-7005
1791-7530
language eng
recordid cdi_proquest_miscellaneous_907178867
source Elektronische Zeitschriftenbibliothek (Open access); MEDLINE
subjects Biological and medical sciences
Biomarkers, Tumor - blood
Biomarkers, Tumor - genetics
DNA - blood
DNA - genetics
Epigenesis, Genetic
Humans
Medical sciences
Microsatellite Repeats - genetics
Tumors
title Cell-free DNA in the Circulation as a Potential Cancer Biomarker
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T21%3A50%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cell-free%20DNA%20in%20the%20Circulation%20as%20a%20Potential%20Cancer%20Biomarker&rft.jtitle=Anticancer%20research&rft.au=KOHLER,%20Corina&rft.date=2011-08-01&rft.volume=31&rft.issue=8&rft.spage=2623&rft.epage=2628&rft.pages=2623-2628&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E907178867%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=878822792&rft_id=info:pmid/21778314&rfr_iscdi=true